Showing 35,310 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

Opportunistic infections

Improved treatment for cryptococcal meningitis in HIV could save thousands of lives – if generic drug becomes available

News
24 July 2017
Undetectable viral load & treatment as prevention

Swaziland: new infections halved in five years as HIV treatment scales up

News
24 July 2017
New & experimental HIV treatments

Long-acting cabotegravir + rilpivirine injection shows good results at 96 weeks

News
24 July 2017
PrEP programmes & uptake

London gonorrhoea rates fall, and HIV rates falling in Australia as more join PrEP demo

News
24 July 2017
Global health targets

World on track to reach the 90-90-90 targets for HIV treatment by 2020

News
23 July 2017
Opportunistic infections

WHO recommends package of tests, treatment and prevention for 'urgent need' people with HIV with low CD4 counts

News
23 July 2017
Exposure to HIV through medical procedures

UK: Blood donation rules relaxed for gay men and sex workers

Editor's pick
BBC
23 July 2017
Starting treatment

Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

Editor's pick
World Health Organization
23 July 2017
The search for a cure

HIV and cancer teams double up to seek out new disease killers

Editor's pick
Reuters
22 July 2017
New & experimental hepatitis C treatment

WHO prequalifies first generic hepatitis C medicine and first HIV self-test

Editor's pick
World Health Organization
22 July 2017
Types of HIV tests

OraSure Technologies Receives World Health Organization Prequalification of OraQuick® HIV Self-Test

Editor's pick
Orasure press release
22 July 2017
New & experimental HIV treatments

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV

Editor's pick
Business Wire
21 July 2017
Government, leadership & policy

The HIV response in Ukraine: at a crossroads

Editor's pick
The Lancet (free registration required)
21 July 2017
Money

PIP: Promoting independence?

Editor's pick
NAT
21 July 2017
Finance & funding

Kaiser/UNAIDS Study Finds Donor Government Funding for HIV Declined by 7% in 2016, Falling to Lowest Level Since 2010

Editor's pick
Kaiser Family Foundation
21 July 2017
Finance & funding

Declining Funding and Shrinking Donor Base Imperils Continued Success of HIV Prevention

Editor's pick
AVAC
21 July 2017
Global health initiatives

AIDS deaths are almost half of what they were in 2005 — but experts worry Trump could reverse that

Editor's pick
Mic
21 July 2017
Cancer

Boys Are Being Denied A Vaccine That Prevents Cancer. Why Is This Being Allowed To Happen?

Editor's pick
Huffington Post
21 July 2017
Side effects

Few people with HIV starting raltegravir and dolutegravir change therapy because of side-effects

News
21 July 2017
Resistance

WHO urges action against HIV drug resistance threat

Editor's pick
World Health Organization
20 July 2017
Vaginal rings & topical PrEP

IPM receives multi-year award from UK government to advance technologies for women's HIV

Editor's pick
Eurekalert Medicine & Health
20 July 2017
Chemsex & recreational drug use

Campaigner with drug past warns of 'chemsex' HIV link

Editor's pick
Medical Xpress
20 July 2017
Global health targets

The scales have tipped—UNAIDS announces 19.5 million people on life-saving treatment and AIDS-related deaths halved since 2005

Editor's pick
UNAIDS
20 July 2017
PrEP

Pre-exposure prophylaxis (PrEP) soon in Ukraine

Editor's pick
PO Alliance Global
20 July 2017